Previous Close | 88.23 |
Open | 86.58 |
Bid | 86.80 x 800 |
Ask | 88.28 x 800 |
Day's Range | 85.60 - 86.59 |
52 Week Range | 74.09 - 94.26 |
Volume | |
Avg. Volume | 2,010,163 |
Market Cap | 182.498B |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | 27.16 |
EPS (TTM) | 3.17 |
Earnings Date | N/A |
Forward Dividend & Yield | 3.33 (3.77%) |
Ex-Dividend Date | Mar 08, 2022 |
1y Target Est | 104.25 |
Novartis ( VTX:NOVN ) Full Year 2022 Results Key Financial Results Revenue: US$51.8b (down 2.0% from FY 2021). Net...
Novartis (NVS) reports mixed fourth-quarter results, with key brands maintaining momentum but Cosentyx sales declining and generic competition remaining a drag.
NVS earnings call for the period ending December 31, 2022.